tiprankstipranks
Trending News
More News >
CytomX Therapeutics Inc (CTMX)
NASDAQ:CTMX

CytomX Therapeutics (CTMX) Revenue

Compare
877 Followers

CytomX Therapeutics Revenue

CytomX Therapeutics had a revenue of 5.96M in the quarter ending Sep 30, 2025, with -68.04%. This bring the company's revenue in the last twelve months to 113.63M, Increased -19.47%. In the fiscal year ending Dec 31, 2024, CytomX Therapeutics had annual revenue of 138.10M with 36.45% growth.
Revenue (ttm)
113.63M
Revenue Growth
-10.26%
P/S Ratio
5.39
Revenue/Employee
$1,160,529
Employees
119
Market Cap
$743.82M

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2024
138.10M36.89M+136.45%
Dec 31, 2023
101.21M48.05M+190.38%
Dec 31, 2022
53.16M15.85M+142.48%
Dec 31, 2021
37.31M-31.11M+54.53%
Dec 31, 2020
68.43M10.94M+119.03%
Dec 31, 2019
57.49M-2.01M+96.62%
Dec 31, 2018
59.50M-12.12M+83.08%
Dec 31, 2017
71.62M56.58M+476.12%
Dec 31, 2016
15.04M